268 related articles for article (PubMed ID: 20713596)
61. The expression of the hepatocyte SLAMF3 (CD229) receptor enhances the hepatitis C virus infection.
Cartier F; Marcq I; Douam F; Ossart C; Regnier A; Debuysscher V; Lavillette D; Bouhlal H
PLoS One; 2014; 9(6):e99601. PubMed ID: 24927415
[TBL] [Abstract][Full Text] [Related]
62. Functional and immunogenic characterization of diverse HCV glycoprotein E2 variants.
Khera T; Behrendt P; Bankwitz D; Brown RJP; Todt D; Doepke M; Khan AG; Schulze K; Law J; Logan M; Hockman D; Wong JAJ; Dold L; Gonzalez-Motos V; Spengler U; Viejo-Borbolla A; Ströh LJ; Krey T; Tarr AW; Steinmann E; Manns MP; Klein F; Guzman CA; Marcotrigiano J; Houghton M; Pietschmann T
J Hepatol; 2019 Apr; 70(4):593-602. PubMed ID: 30439392
[TBL] [Abstract][Full Text] [Related]
63. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies.
Farci P; Shimoda A; Coiana A; Diaz G; Peddis G; Melpolder JC; Strazzera A; Chien DY; Munoz SJ; Balestrieri A; Purcell RH; Alter HJ
Science; 2000 Apr; 288(5464):339-44. PubMed ID: 10764648
[TBL] [Abstract][Full Text] [Related]
64. Characterization of Hepatitis C Virus (HCV) Envelope Diversification from Acute to Chronic Infection within a Sexually Transmitted HCV Cluster by Using Single-Molecule, Real-Time Sequencing.
Ho CKY; Raghwani J; Koekkoek S; Liang RH; Van der Meer JTM; Van Der Valk M; De Jong M; Pybus OG; Schinkel J; Molenkamp R
J Virol; 2017 Mar; 91(6):. PubMed ID: 28077634
[TBL] [Abstract][Full Text] [Related]
65. A protein coevolution method uncovers critical features of the Hepatitis C Virus fusion mechanism.
Douam F; Fusil F; Enguehard M; Dib L; Nadalin F; Schwaller L; Hrebikova G; Mancip J; Mailly L; Montserret R; Ding Q; Maisse C; Carlot E; Xu K; Verhoeyen E; Baumert TF; Ploss A; Carbone A; Cosset FL; Lavillette D
PLoS Pathog; 2018 Mar; 14(3):e1006908. PubMed ID: 29505618
[TBL] [Abstract][Full Text] [Related]
66. Pathogen-Associated Molecular Pattern Recognition of Hepatitis C Virus Transmitted/Founder Variants by RIG-I Is Dependent on U-Core Length.
Kell A; Stoddard M; Li H; Marcotrigiano J; Shaw GM; Gale M
J Virol; 2015 Nov; 89(21):11056-68. PubMed ID: 26311867
[TBL] [Abstract][Full Text] [Related]
67. An Optimized Hepatitis C Virus E2 Glycoprotein Core Adopts a Functional Homodimer That Efficiently Blocks Virus Entry.
McCaffrey K; Boo I; Owczarek CM; Hardy MP; Perugini MA; Fabri L; Scotney P; Poumbourios P; Drummer HE
J Virol; 2017 Mar; 91(5):. PubMed ID: 28031364
[TBL] [Abstract][Full Text] [Related]
68. Studies on the role of neutralizing antibodies against envelope genes in resolving HCV pseudo-particles infection.
Rafique S; Idrees M; Ali A; Iqbal M
Mol Biol Rep; 2014 Jun; 41(6):3945-50. PubMed ID: 24566682
[TBL] [Abstract][Full Text] [Related]
69. A Role for B Cells to Transmit Hepatitis C Virus Infection.
Desombere I; Van Houtte F; Farhoudi A; Verhoye L; Buysschaert C; Gijbels Y; Couvent S; Swinnen W; Van Vlierberghe H; Elewaut A; Magri A; Stamataki Z; Meuleman P; McKeating JA; Leroux-Roels G
Front Immunol; 2021; 12():775098. PubMed ID: 34975862
[TBL] [Abstract][Full Text] [Related]
70. Entry inhibitors and future treatment of hepatitis C.
Fofana I; Jilg N; Chung RT; Baumert TF
Antiviral Res; 2014 Apr; 104():136-42. PubMed ID: 24525381
[TBL] [Abstract][Full Text] [Related]
71. High density lipoprotein inhibits hepatitis C virus-neutralizing antibodies by stimulating cell entry via activation of the scavenger receptor BI.
Dreux M; Pietschmann T; Granier C; Voisset C; Ricard-Blum S; Mangeot PE; Keck Z; Foung S; Vu-Dac N; Dubuisson J; Bartenschlager R; Lavillette D; Cosset FL
J Biol Chem; 2006 Jul; 281(27):18285-95. PubMed ID: 16675450
[TBL] [Abstract][Full Text] [Related]
72. Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo.
Meuleman P; Hesselgesser J; Paulson M; Vanwolleghem T; Desombere I; Reiser H; Leroux-Roels G
Hepatology; 2008 Dec; 48(6):1761-8. PubMed ID: 19030166
[TBL] [Abstract][Full Text] [Related]
73. Hepatitis C Virus Escape Studies of Human Antibody AR3A Reveal a High Barrier to Resistance and Novel Insights on Viral Antibody Evasion Mechanisms.
Velázquez-Moctezuma R; Galli A; Law M; Bukh J; Prentoe J
J Virol; 2019 Feb; 93(4):. PubMed ID: 30487284
[TBL] [Abstract][Full Text] [Related]
74. Determination of the human antibody response to the epitope defined by the hepatitis C virus-neutralizing monoclonal antibody AP33.
Tarr AW; Owsianka AM; Jayaraj D; Brown RJP; Hickling TP; Irving WL; Patel AH; Ball JK
J Gen Virol; 2007 Nov; 88(Pt 11):2991-3001. PubMed ID: 17947521
[TBL] [Abstract][Full Text] [Related]
75. Glycan Shielding and Modulation of Hepatitis C Virus Neutralizing Antibodies.
Lavie M; Hanoulle X; Dubuisson J
Front Immunol; 2018; 9():910. PubMed ID: 29755477
[TBL] [Abstract][Full Text] [Related]
76. The role of neutralizing antibodies in hepatitis C virus infection.
Edwards VC; Tarr AW; Urbanowicz RA; Ball JK
J Gen Virol; 2012 Jan; 93(Pt 1):1-19. PubMed ID: 22049091
[TBL] [Abstract][Full Text] [Related]
77. Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies.
Stamataki Z; Coates S; Evans MJ; Wininger M; Crawford K; Dong C; Fong YL; Chien D; Abrignani S; Balfe P; Rice CM; McKeating JA; Houghton M
Vaccine; 2007 Nov; 25(45):7773-84. PubMed ID: 17919789
[TBL] [Abstract][Full Text] [Related]
78. Neutralizing antibody response to hepatitis C virus.
Wang Y; Keck ZY; Foung SK
Viruses; 2011 Nov; 3(11):2127-45. PubMed ID: 22163337
[TBL] [Abstract][Full Text] [Related]
79. A neutralization epitope in the hepatitis C virus E2 glycoprotein interacts with host entry factor CD81.
Zhao Z; Zhong L; Elrod E; Struble E; Ma L; Yan H; Harman C; Deng L; Virata-Theimer ML; Liu P; Alter H; Grakoui A; Zhang P
PLoS One; 2014; 9(1):e84346. PubMed ID: 24400084
[TBL] [Abstract][Full Text] [Related]
80. The association of CD81 with tetraspanin-enriched microdomains is not essential for Hepatitis C virus entry.
Rocha-Perugini V; Lavie M; Delgrange D; Canton J; Pillez A; Potel J; Lecoeur C; Rubinstein E; Dubuisson J; Wychowski C; Cocquerel L
BMC Microbiol; 2009 May; 9():111. PubMed ID: 19476617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
